|
JP2012121914A
|
|
Alleviator for radiation disorder
|
|
WO2012063964A1
|
|
Near intrared-absorbing cyanine pigment and use thereof
|
|
WO2012060471A1
|
|
Method for treating photosensitive silver halide material for hologram, and bleached phase hologram obtained using this treatment method
|
|
JP2012025780A
|
|
Photofunctional material
|
|
WO2012039508A1
|
|
Pyrrolopyridine compound and use thereof
|
|
WO2012014805A1
|
|
Nitric oxide generation regulator
|
|
JP2012000108A
|
|
Invertase inhibitor and application of the same
|
|
JP2012221937A
|
|
Lighting device with led as light source
|
|
WO2011108762A1
|
|
Prophylactic and/or ameliorating agent for insulin resistance
|
|
SG180307A1
|
|
Powder containing anhydrous crystals of 2-o-a-d-glucosyl-l-ascorbic acid, manufacturing method therefor, and use thereof
|
|
JP2012016309A
|
|
Maltotriose-forming amylase, production method and use thereof
|
|
JP2010189448A
|
|
Therapeutic agent for bovine digestive disorder
|
|
JP2011223910A
|
|
α-GLUCOSIDASE, METHOD FOR PRODUCING THE SAME AND USE OF THE SAME
|
|
WO2010087315A1
|
|
Anti-alzheimer’s disease agent
|
|
WO2010090095A1
|
|
Cellobiose 2-epimerase, process for producing same, and use of same
|
|
WO2010087313A1
|
|
Neurite elongation stimulator
|
|
JP2010070568A
|
|
Composition for control and/or prevention of abnormal production of cytokines in mammals
|
|
JP2010051327A
|
|
Method for screening organic coloring compound for receptor potential inducer
|
|
JP2010148502A
|
|
METHOD FOR PRODUCING beta-PHOSPHOGLUCOMUTASE, METHOD FOR PRODUCING THE SAME AND USE THEREOF
|
|
JP2010100853A
|
|
Merocyanine-based pigment
|
